A nationwide cohort study of the role of CHADS₂ score in predicting lower extremity amputation and death among patients with peripheral arterial occlusive disease

References

• Stone NJ, Robinson JG, Lichtenstein AH, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1–S45.
   Web of Science ®Google Scholar
• Achterberg S, Cramer MJ, Kappelle LJ, et al.; SMART study Group. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study. Eur J Cardiovasc Prev Rehabil. 2010;17:424–430.
   PubMedGoogle Scholar
• Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag. 2007;3:229–234.
   PubMedGoogle Scholar
• Ogawa S, Aonuma K, Tse HF, et al. TheAPHRS’s 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation. J Arrhythm. 2013;29:190–200.
   Google Scholar
• Fuster V, Rydén LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011;57:e101–e198.
   PubMed Web of Science ®Google Scholar
• Sun GZ, Ye N, Zhang NJ, et al. Association between CHADS2 score, depressive symptoms, and quality of life in a general population. BMC Psychiatry. 2017;17:80.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Chen TH, Su YW, et al. Usefulness of the CHADS2 score for determining risk of seizure in patients with atrial fibrillation. Am J Cardiol. 2016;118:1340–1344.
   PubMed Web of Science ®Google Scholar
• Huang SS, Chan WL, Leu HB, et al. Association between CHADS2 score and the preventive effect of statin therapy on new-onset atrial fibrillation in patients with acute myocardial infarction. PLoS One. 2013;8:e74709.
   PubMed Web of Science ®Google Scholar
• National Health Research Institutes. National Health Insurance Research Database. [cited 2015 Apr 14]. Available from: http://nhird.nhri.org.tw/en/index.html
   Google Scholar
• Hu WS, Lin CL. Association between cataract and risk of incident atrial fibrillation: a nationwide population-based retrospective cohort study. Mayo Clin Proc. 2017;92:370–375.
   PubMed Web of Science ®Google Scholar
• Lin CJ, Liao WC, Chen YA, et al. Statin therapy is associated with reduced risk of peptic ulcer disease in the Taiwanese population. Front Pharmacol. 2017;8:210.
   PubMed Web of Science ®Google Scholar
• Yang YW, Chen YH, Hsu CC, et al. CHADS2 scores as a predictor of ischemic stroke in patients with peripheral artery disease. Mayo Clin Proc. 2016;91:45–50.
   PubMed Web of Science ®Google Scholar
• Chao TF, Liu CJ, Tuan TC, et al. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: which scoring system should be used for Asians. Heart Rhythm. 2016;13:46–53.
   PubMed Web of Science ®Google Scholar
• Chao TF, Liu CJ, Wang KL, et al. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. Heart Rhythm. 2014;11:1752–1759.
   PubMed Web of Science ®Google Scholar
• Chao TF, Liu CJ, Chen SJ, et al. CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan. Int J Cardiol. 2013;168:1360–1363.
   PubMed Web of Science ®Google Scholar
• Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387.
   PubMed Web of Science ®Google Scholar
• Swaminathan A, Vemulapalli S, Patel MR, et al. Lower extremity amputation in peripheral artery disease: improving patient outcomes. Vasc Health Risk Manag. 2014;10:417–424.
   PubMedGoogle Scholar
• Jones WS, Patel MR, Dai D, et al. Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from US Medicare 2000–2008. J Am Coll Cardiol. 2012;60:2230–2236.
   PubMed Web of Science ®Google Scholar
• Amrock SM, Weitzman M. Multiple biomarkers for mortality prediction in peripheral arterial disease. Vasc Med. 2016;21:105–112.
   PubMed Web of Science ®Google Scholar
• Hackl G, Belaj K, Gary T, et al. COPART risk score predicts long-term mortality in peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg. 2015;50:94–100.
   PubMed Web of Science ®Google Scholar
• Moxey PW, Brownrigg J, Kumar SS, et al. The BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison with the FINNVASC and modified PREVENT scores. J Vasc Surg. 2013;57:1–7.
   PubMed Web of Science ®Google Scholar
• Feringa HH, Bax JJ, Hoeks S, et al. A prognostic risk index for long-term mortality in patients with peripheral arterial disease. Arch Intern Med. 2007;167:2482–2489.
   PubMedGoogle Scholar
• Sprengers RW, Janssen KJ, Moll FL, SMART Study Group, et al. Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study. J Vasc Surg. 2009;50:1369–1376.
   PubMed Web of Science ®Google Scholar
• Schanzer A, Mega J, Meadows J, et al. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48:1464–1471.
   PubMed Web of Science ®Google Scholar
• Gary T, Belaj K, Hafner F, et al. Graz critical limb ischemia score: a risk score for critical limb ischemia in peripheral arterial occlusive disease. Medicine. 2015;94:e1054.
   PubMed Web of Science ®Google Scholar
• Gary T, Belaj K, Hafner F, et al. A high CHA(2)DS(2)-VASc score is associated with a high risk for critical limb ischemia in peripheral arterial occlusive disease patients. Atherosclerosis. 2012;225:517–520.
   PubMed Web of Science ®Google Scholar